Haemophilia: January 2008

Haemophilia

Volumn 14, Issue 1, 2008, Pages 1-4

  Lee, Christine ^a   Kessler, Craig ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DECISION MAKING; EDITORIAL; HEALTH CARE ACCESS; HEMOPHILIA; INTERNET; MEDICAL LITERATURE; PRIORITY JOURNAL; PUBLICATION; QUALITY CONTROL; WORLD HEALTH ORGANIZATION;

EID: 37749001672     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2007.01624.x     Document Type: Editorial

References (25)

1. Villar A, Aronis S, Morfini M et.al. Pharmacokinetics of activated recombinant coagulation factor VII (NovoSeven (R)) in children vs adults with haemophilia A. Haemophilia 2004; 10: 352-9.
2. Laffan M, Brown SA, Collins PW et.al. The diagnosis of von Willebrand disease: A guideline from the UK Haemophilia Centre Doctors'Organization. Haemophilia 2004; 10: 199-217.
3. Parameswaran R, Shapiro AD, Gill JC et.al. Dose effect and efficacy of rFVIIa in the treatment of haemophilia patients with inhibitors: analysis from the Hemophilia and Thrombosis Research Society Registry. Haemophilia 2005; 11: 100-6.
4. Bolton-Maggs PHB, Perry DJ, Chalmers EA et.al. The rare coagulation disorders - review with guidelines for management from the United Kingdom Haemophilia Centre Doctors'Organisation. Haemophilia 2004; 10: 593-628.
5. Parapia LA, Wilde JT, Williams MD et.al. Variant Creutzfeldt-Jakob disease: Risk of transmission by blood and blood products. Haemophilia 2004; 10: 64-9.
6. Schneiderman J, Nugent DJ, Young G. Sequential therapy with activated prothrombin complex concentrate and recombinant factor VIIa in patients with severe haemophilia and inhibitors. Haemophilia 2004; 10: 347-51.
7. Young G, McDaniel M, Nugent DJ. Prophylactic recombinant factor VIIa in haemophilia patients with inhibitors. Haemophilia 2005; 11: 203-7.
8. Blanchette VS, Manco-Johnson M, Santagostino E et.al. Optimizing factor prophylaxis for the haemophilia population: Where do we stand? Haemophilia 2004; 10: 97-104.
9. Huang YW, Saidi P, Philipp C. Acquired factor VIII inhibitors in non-haemophilic patients: Clinical experience of 15 cases. Haemophilia 2004; 10: 713-72.
10. Ewenstein BM, Valentino LA, Journeycake JM et.al. Consensus recommendations for use of central venous access devices in haemophilia. Haemophilia 2004; 10: 629-48.
11. von Mackensen S, Bullinger M. Development and testing of an instrument to assess the Quality of Life of Children with Haemophilia in Europe (Haemo-QoL). Haemophilia 2004; 10: 17-25.
12. Luu H, Ewenstein B. FEIBA (R) safety profile in multiple modes of clinical and home-therapy application. Haemophilia 2004; 10: 174-8.
13. Dargaud Y, Meunier S, Negrier C. Haemophilia and thrombophilia: An unexpected association!. Haemophilia 2004; 10: 319-26.
14. Valentino LA, Ewenstein B, Navickis RJ et.al. Central venous access devices in haemophilia. Haemophilia 2004; 10: 134-46.
15. Morado M, Villar A, Yuste VJ et.al. Prophylactic treatment effects on inhibitor risk: Experience in one centre. Haemophilia 2005; 11: 203-7.
16. Lee M, Morfini M, Negrier C et.al. The pharmacokinetics of coagulation factors. Haemophilia 2006; 12: 1-7.
17. De Kleijn P, Blamey G, Zourikian N et.al. Physiotherapy following elective orthopaedic procedures. Haemophilia 2006; 12: 108-12.
18. Astermark J. Why do inhibitors develop? Principles of and factors influencing the risk for inhibitor development in haemophilia. Haemophilia 2006; 12: 52-60.
19. Barrowcliffe TW, Cattaneo M, Podda GM et.al. New approaches for measuring coagulation. Haemophilia 2006; 12: 76-81.
20. Hayward CPM, Rao AK, Cattaneo M. Congenital platelet disorders: Overview of their mechanisms, diagnostic evaluation and treatment. Haemophilia 2006; 12: 128-36.
21. Gringeri A, Mannucci PM. Italian guidelines for the diagnosis and treatment of patients with haemophilia and inhibitors. Haemophilia 2005; 11: 611-99.
22. Lillicrap D, Nair SC, Srivastava A. Laboratory issues in bleeding disorders. Haemophilia 2006; 12: 68-75.
23. Peyvandi F, Jayandharan G, Chandy M et.al. Genetic diagnosis of haemophilia and other inherited bleeding disorders. Haemophilia 2006; 12: 82-9.
24. Saenko EL, Pipe SW. Strategies towards a longer acting factor VIII. Haemophilia 2006; 12: 42-51.
25. Federici AB, Castaman G, Thompson A. Von Willebrand's disease: Clinical management. Haemophilia 2006; 12: 152-8.